Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06750874 · ClinicalTrials.gov registry record · NA

Perioperative ACT for Preventing CPSP: a Single-arm Non-randomized Pilot Trial

A NA study of Back Pain and Spondylolisthesis, sponsored by Samantha Meints.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06750874: Completed NA study of Back Pain and Spondylolisthesis, sponsored by Samantha Meints.

NCT06750874 is a NA study of Back Pain and Spondylolisthesis that has completed, run by Samantha Meints. The registered enrollment target is 45 participants, below the 141-participant average among 37 other Back Pain trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06750874, a NA study of Back Pain and Spondylolisthesis, has completed, sponsored by Samantha Meints.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The present study aims to adapt and modify a brief perioperative Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will assess the acceptability, feasibility, and preliminary efficacy of the intervention via a non-randomized, non-controlled pilot trial.

Primary Outcome

Item assesses the perceived helpfulness of the ACT workshop and is rated from -5 (extremely harmful) to 5 (extremely helpful).

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Chestnut Hill

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2023-01-04
Est. Completion 2024-02-22
Phase NA
Samantha Meints

1 total trials

What the finished NCT06750874 record still lists

NCT06750874 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 141-participant average among 37 other Back Pain trials with a reported enrollment target (68% lower).

The record links to 5 conditions, with Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT06750874 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06750874 about?

NCT06750874 is a clinical study titled "Perioperative ACT for Preventing CPSP: a Single-arm Non-randomized Pilot Trial". The present study aims to adapt and modify a brief perioperative Acceptance and Commitment Therapy (ACT) intervention aimed at preventing the transition to Chronic Post-Surgical Pain (CPSP) and reducing long-term opioid use. Investigators will assess the acceptability, feasibility, and preliminary e...

What is the current status of trial NCT06750874?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2023-01-04. Estimated completion is 2024-02-22.

What conditions does trial NCT06750874 study?

This clinical trial studies the following conditions: Back Pain, Spondylolisthesis, Spinal Stenosis, Spondylosis, Back Injury.

What interventions are being tested in trial NCT06750874?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06750874?

This trial is sponsored by Samantha Meints, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06750874 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06750874's enrollment target sits among peer trials

45 29th of 37 higher than 9 of 37 other Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00804154 · 45 participants · Phase 1

    Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

  • NCT01851694 · 45 participants · NA

    Beta-cell Response to Incretin Hormones in Cystic Fibrosis

  • NCT02896335 · 45 participants · Phase 2

    Palbociclib and Pembrolizumab In Central Nervous System Metastases

  • NCT03454035 · 45 participants · Phase 1

    Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06750874, the US trial registry maintained by the National Library of Medicine. NCT06750874 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.